Back to Directory
IOTA Pharmaceuticals
East of England
Founded 2007
Fragment-based drug discovery with a glioblastoma focus
IOTA Pharmaceuticals is a Cambridge drug discovery company specialising in fragment-based design, molecular screening and computational approaches to early-stage therapeutics.
Its research combines transcriptomics, phenotypic assays and natural product screening to investigate candidate treatments. A major focus is glioblastoma, where the company has contributed to collaborative studies of drug combinations and tumour responses.
Founded in 2007, IOTA works with academic and pharmaceutical partners to advance discovery programmes.